UTHSC News: Researcher Pioneers Faster, Cheaper Gene Therapy for Hemoglobin Disorders

For millions living with hemoglobin deficiencies such as sickle cell disease or beta thalassemia, every day is a battle against pain, costly treatments, and uncertainty. Dr. Frank Park is racing to help.

A new gene therapy being developed at the University of Tennessee Health Science Center could provide a more accessible cure. Frank Park, PhD, a researcher at UT Health Sciences' College of Pharmacy, believes he's on the verge of a more efficient and affordable solution that could revolutionize how we combat hemoglobin deficiencies through his gene therapy, nicknamed "Minirolu."

"My main goal isn't to make money," Dr. Park said. "I've been working on this for almost a year for free, because of my background in vector biology and genome manipulation."

Read more on the UT Health Sciences News website.